서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 15 of 15

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2001-04	Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study Kang, Won Ki; Park, Chaehwa; Yoon, Hyunah Lee; Kim, Won Seog; Yoon, Sung-Soo; Lee, Mark H.; Park, Keunchil; Kim, Kihyun; Jeong, Hyun Sik; Kim, Jeong-A; Nam, Seok-Jin; Yang, Jung-Hyun; Son, Young-Ik; Baek, Chung-Hwan; Han, Jungho; Ree, Howe J.; Lee, Eil Soo; Kim, Sun Hee; Kim, Dae-Won; Ahn, Yong Chan; Huh, Seung Jae; Choe, Yeon Hyeon; Lee, Je-Ho; Park, Mary H.; Kong, Gyoung-Sun; Park, Eun-Young; Kang, Yoon-Koo; Bang, Yung-Jue; Paik, Nam-Sun; Lee, Soon Nam; Kim, Seon-Hee; Kim, Sunyoung; Robbins, Paul D.; Tahara, Hideaki; Lotze, Michael T.; Park, Chan H. Human Gene Therapy, Vol.12 No.6, pp.671-684	DOI
2002	Importance of open lung biopsy in the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies Kim, Kihyun; Lee, Mark H.; Kim, Jingook; Lee, Kyung Soo; Kim, Sung Min; Jung, Man Pyo; Han, Joungho; Sung, Ki Woong; Kim, Won Seog; Jung, Chul Won; Yoon, Sung Soo; Im, Young-Hyuck; Kang, Won Ki; Park, Keunchil; Park, Chan Hyung Am J Hematol 2002;71:75-79	link
2002-07	Docetaxel 75 mg/m2 is active and well tolerated in patients with metastatic or recurrent gastric cancer: A phase II trial Bang, Yung-Jue; Kang, Won Ki; Kang, Yoon-Koo; Kim, Hugh Chul; Jacques, Christian; Zuber, Emmanuel; Daglish, Byzance; Boudraa, Yvane; Kim, Won Seog; Heo, Dae Seog; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.32 No.7, pp.248-254	DOI
2002-09	Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial Bang, Yung-Jue; Kang, Won Ki; Kang, Yoon-Koo; Kim, Hugh Chul; Jacques, Christian; Zuber, Emmanuel; Daglish, Byzance; Boudraa, Yvane; Kim, Won Seog; Heo, Dae Seog; Kim, Noe Kyeong Jpn J Clin Oncol 2002;32:248-54	link
2004-11	A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer Park, Sook Ryun; Oh, Do Youn; Kim, Dong Wan; Kim, Tae You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong; Kang, Won Ki; Kim, Heung-Tae; Im, Seock Ah; Suh, Jae-Hong; Kim, Hark-Kyun; Kim, Hoon-Kyo Oncology Reports, Vol.12 No.5, pp.1059-1064	DOI
2007-07	Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea-Japan collaborative study group trial Kim, Yeul Hong; Yamaguchi, Kensei; Bang, Yung-Jue; Takiuchi, Hiroya; Kang, Won Ki; Sato, Atsushi; Kang, Yoon-Koo; Sakamoto, Junichi; Abe, Chigusa; Sakata, Yuh Japanese Journal of Clinical Oncology, Vol.37 No.7, pp.501-508	DOI
2008-07	Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study Kim, Yeul Hong; Chung, Hyun Cheol; Kang, Won Ki; Park, Sook Ryun; Kim, Chul Soo; Kim, Tae-Yue; Shin, Sang Won; Park, Byung-Joo; Cha, Soo Jin; Bang, Yung-Jue Cancer Chemotherapy and Pharmacology, Vol.62 No.2, pp.263-270	DOI
2009	Kinase Mutations and Efficacy of Imatinib in Korean Patients with Advanced Gastrointestinal Stromal Tumors Kim, Tae Won; Ryu, Min-Hee; Lee, Heungnam; Sym, Sun Jin; Lee, Jae-Lyun; Chang, Heung Moon; Park, Young Suk; Lee, Kyung Hee; Kang, Won Ki; Shin, Dong Bok; Bang, Yung-Jue; Lee, Jung Shin; Kang, Yoon-Koo Oncologist, Vol.14 No.5, pp.540-547	DOI
2009-01	Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study Lee, Jeeyun; Jung, Kyung Hae; Park, Young Suk; Ahn, Joong Bae; Shin, Sang Jun; Im, Seock-Ah; Oh, Do Youn; Shin, Dong Bok; Kim, Tae Won; Lee, Namsu; Byun, Jae Ho; Hong, Yong Sang; Park, Joon Oh; Park, Se Hoon; Lim, Ho Yeong; Kang, Won Ki Cancer Chemother Pharmacol. 2009 Sep;64(4):657-63. Epub 2009 Jan 24.	link
2009-04	A Prospective, Multicenter, Phase 2 Study of Imatinib Mesylate in Korean Patients with Metastatic or Unresectable Gastrointestinal Stromal Tumor Ryu, Min-Hee; Kang, Won Ki; Bang, Yung-Jue; Lee, Kyung Hee; Shin, Dong Bok; Ryoo, Baek-Yeol; Roh, Jae Kyung; Kang, Jin-Hyoung; Lee, Hyoungnam; Kim, Tae Won; Chang, Heung Moon; Park, Joon Oh; Park, Young Suk; Kim, Tae-You; Kim, Min Kyoung; Lee, Woon Kee; Kang, Hye Jin; Kang, Yoon-Koo Oncology, Vol.76 No.5, pp.326-332	DOI
2009-09	Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study Lee, Jeeyun; Jung, Kyung Hae; Park, Young Suk; Ahn, Joong Bae; Shin, Sang Jun; Im, Seock-Ah; Oh, Do Youn; Shin, Dong Bok; Kim, Tae Won; Lee, Namsu; Byun, Jae Ho; Hong, Yong Sang; Park, Joon Oh; Park, Se Hoon; Lim, Ho Yeong; Kang, Won Ki Cancer Chemotherapy and Pharmacology, Vol.64 No.4, pp.657-663	DOI
2013-01	Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation Kang, Yoon-Koo; Kang, Byung Woog; Im, Seock-Ah; Lee, Jae-Lyun; Park, Sook Ryun; Kang, Won Ki; Chang, Heung Moon; Kim, Tae Won; Oh, Do-Youn; Jung, Kyung Hae; Ryu, Min-Hee Cancer Chemotherapy and Pharmacology, Vol.71 No.1, pp.43-51	DOI
2013-02	Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation (vol 71, pg 43, 2013) Kang, Yoon-Koo; Kang, Byung Woog; Im, Seock-Ah; Lee, Jae-Lyun; Park, Sook Ryun; Kang, Won Ki; Chang, Heung Moon; Kim, Tae Won; Oh, Do-Youn; Jung, Kyung Hae; Ryu, Min-Hee Cancer Chemotherapy and Pharmacology, Vol.71 No.2, pp.551-552	DOI
2013-04	Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer Lee, Kyung-Hun; Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Sun Young; Lee, Keun-Wook; Kim, Jee Hyun; Hong, Yong Sang; Kim, Tae Won; Park, Young Suk; Kang, Won Ki; Shin, Sang Joon; Ahn, Joong Bae; Kang, Gyeong Hoon; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.71 No.4, pp.843-851	DOI
2016-10	Phase II trial of dacomitinib in patients with HER2-positive gastric cancer Oh, Do-Youn; Lee, Kewn-Wook; Cho, Jae Yong; Kang, Won Ki; Im, Seock-Ah; Kim, Jin Won; Bang, Yung-Jue Gastric Cancer, Vol.19 No.4, pp.1095-1103	DOI

1